Free Trial

Applied Therapeutics (APLT) Earnings Date, Estimates & Call Transcripts

Applied Therapeutics logo
$0.10 0.00 (0.00%)
As of 05/8/2026

Applied Therapeutics Earnings Summary

Applied Therapeutics announced Q3 2025 earnings on November 13, 2025, reporting an EPS of -$0.13, which topped the consensus estimate of -$0.15 by $0.02. Quarterly revenue was reported to be $1 million, above analysts' expectations of $0.25 million. With a trailing EPS of -$0.10, Applied Therapeutics' earnings are expected to grow next year, from ($0.65) to ($0.62) per share.

Consensus EPS
(Nov. 13)
-$0.15
Actual EPS
(Nov. 13)
-$0.13 Beat By $0.02
Actual Revenue
(Nov. 13)
$1.00M

Q3 2025 Earnings Resources

Get Applied Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

APLT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APLT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Applied Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.16-$0.14-$0.15
Q2 20262-$0.17-$0.14-$0.16
Q3 20262-$0.16-$0.04-$0.10
Q4 20262-$0.14-$0.10-$0.12

Applied Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2025Q3 2025-$0.15-$0.13+$0.02-$0.13$0.25M$1.00M
8/13/2025Q2 2025-$0.17-$0.15+$0.02-$0.15$0.42M-
4/14/2025Q4 2024-$0.18-$0.24 -$0.06$0.33$0.61M-$0.00M
8/7/2024Q2 2024-$0.10-$0.13 -$0.03-$0.13$10.00M$0.14M

Data powered by Fiscal.ai.

Applied Therapeutics Earnings - Frequently Asked Questions

Applied Therapeutics (NASDAQ:APLT) last announced its quarterly earning data on Thursday, November 13, 2025. Learn more on APLT's earnings history.

In the previous quarter, Applied Therapeutics (NASDAQ:APLT) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.02. Learn more on analysts' earnings estimate vs. APLT's actual earnings.

Applied Therapeutics (NASDAQ:APLT) has a recorded annual revenue of $1 million.

Applied Therapeutics (NASDAQ:APLT) has a recorded net income of -$105.62 million. APLT has generated -$0.10 earnings per share over the last four quarters.

Applied Therapeutics' earnings are expected to grow from ($0.65) per share to ($0.62) per share in the next year.


This page (NASDAQ:APLT) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners